May 19, 2016
Fourth Issue, Series Two Personalized Treatment Planning
Personalized Treatment Planning: A Physician’s Perspective
In this issue of Conquering the Cancer Care Continuum, Ms Faiman and Dr Stricker focus on aspects of treatment planning in cancer patients. While they come at the topic from slightly different angles, both cases illustrate that deciding on whether to treat patients, which drugs to use, and what other [ Read More ]
Personalized Treatment Planning
The fourth issue of Conquering the Cancer Care Continuum series addresses Treatment Planning Through the Cancer Care Continuum. Following are 2 key articles to provide insight into the role of the clinical pharmacologist as a member of the multidisciplinary team working collaboratively to render recommendations about treatment planning options. Gone [ Read More ]
Personalized Treatment Planning: A Nurse’s Perspective
It is projected there will be 18.1 million cancer survivors in 2020, with an estimated $173 billion of associated cancer care costs in the initial and last year of life.1 The cost of healthcare has grown exponentially since the 1990s due, in part, to improved diagnostic techniques, better treatments, and [ Read More ]
Personalized Treatment Planning: A Pharmacist’s Perspective
JS is a 62-year-old female diagnosed with a stage IIB (T2, N1, M0), estrogen receptor/progesterone receptor–negative, HER2-negative invasive ductal carcinoma of the breast 18 months ago and treated with bilateral mastectomy followed by adjuvant docetaxel and cyclophosphamide (TC). Recently, she felt an enlarged supraclavicular lymph node that was subsequently biopsied [ Read More ]